Our Story
Founded in 2024, Veron Scientific is a Europe- and Singapore-based provider of Customised Clinical Research Consultancy (CCRC).
We are an innovative start-up in regulatory and clinical trial management, backed by over 25 years of combined industry experience.
Veron Scientific began when our paths crossed in the life sciences industry, united by a conviction that clinical research can move faster and achieve more when freed from unnecessary bureaucracy and supported by genuine collaboration. We built a model that values both innovation and the people behind it.
We prioritise strong site relationships, achievable timelines, and seamless teamwork, acting as an extension of your organisation so every study runs smoothly and efficiently. Guided by our values of diversity, equity, and inclusion, we design research that reflects the real-world populations it serves.
Our services are tailored to each programme, spanning AI-enabled data capture, regulatory strategy, safety monitoring, and clinical operations. Rooted in scientific depth and powered by data, our CCRC model integrates regulatory insight, clinical execution, and data intelligence to accelerate development, ensure compliance, and maximise the value of every programme.
One breakthrough at a time, we’re shaping a healthier tomorrow.
With foundations in Europe, Singapore, the UK, and Scandinavia, we extend our CCRC services internationally — supporting studies wherever patients and expertise are required.
Our Mission
Our mission is to simplify the complexity of clinical development, combining expertise, agility, and precision to turn promising science into life-changing treatments.
Our Approach
Agile, expert-led, purpose-built clinical trial support.
Our CCRC model scales from pilot to pivotal, giving you direct access to senior specialists, integrated capabilities, and global regulatory precision—quality at every step.
What defines our approach
Strategic alignment: We embed with your team to keep clarity and momentum.
Lean & responsive: Fewer layers, faster decisions, closer oversight.
Scalable: Right-level of support—from single-site pilots to multi-country pivotal trials, without wasted cost or unnecessary complexity.
Our Core Values
These values define who we are, shape how we work, and keep us fully committed to your success.
Integrity & Trust
We do the right thing, keep our promises, and earn enduring trust.
Excellence & Passion
Driven by dedication and innovation to deliver quality without compromise.
Courage
We challenge convention, take initiative, and shape smarter, bolder solutions.
Diversity & Inclusion
We value different perspectives, work as one team, and deliver stronger outcomes together.
Our Leaders
Kimlan N. Ibsen
CEO
Founder and Chief Executive Officer of Veron Scientific with over 20 years’ international experience across CROs, sponsors, pharma, biotech, and medical devices. Specialised in oncology, cardiovascular, and rare diseases, with extensive expertise overseeing global Phase I–III trials across Europe and North America, including complex, multi-country programmes. Skilled in sponsor oversight, trial rescue, accelerated start-up, and regulatory submissions (MHRA, EMA, REK, IRAS, CTIS), with deep knowledge of ICH-GCP and ISO 14155 compliance. As CEO, provides the company’s strategic direction and external leadership, building partnerships and driving innovation to deliver faster, more agile clinical development worldwide.
Marc Höhne
CTO
Chief Technology Officer of Veron Scientific, medtech expert with international experience over 30 years. Specialist in cardiology, cardiovascular, neurology and neurostimulation with leadership experience across sales, marketing, therapy and business development. Skilled in national and international clinical trials in enrollment improvement, clinical support and as programme lead for global pivotal trials.
Kimlan N. Ibsen
CEO
Founder and Chief Executive Officer of Veron Scientific with over 20 years’ international experience across CROs, sponsors, pharma, biotech, and medical devices. Specialised in oncology, cardiovascular, and rare diseases, with extensive expertise overseeing global Phase I–III trials across Europe and North America, including complex, multi-country programmes. Skilled in sponsor oversight, trial rescue, accelerated start-up, and regulatory submissions (MHRA, EMA, REK, IRAS, CTIS), with deep knowledge of ICH-GCP and ISO 14155 compliance. As CEO, provides the company’s strategic direction and external leadership, building partnerships and driving innovation to deliver faster, more agile clinical development worldwide.
Marc Höhne
CTO
Founder and Chief Technology Officer of Veron Scientific, a medtech expert with international experience since the early 1990s. Brings leadership across sales, marketing, training, therapy, and business development, and has served as programme lead for a global pivotal trial.
Our Advisors
Cecil Wood
Business Development (BD) expert with 20+ years working with biotech, pharma, and healthtech worldwide. Strong scientific foundation in pharmacology. Proven track record (10 years+) across pre-clinical to clinical operations. BD expertise for CROs, core and central labs, data technologies, healthtech and medical devices. Experienced in early- and late-phase clinical trials and go-to-market strategies. BD Consultant for global network spanning biotech, pharma, start-ups, mid-size, and large companies.
Douglas K. Gordon
An accomplished business leader with over 15 years of experience across wellness, cannabis, and psychedelics industries. Founder of the Natural Mystic Center for Wellness in Jamaica, Douglas has built a reputation as a results-driven executive. Known for his strategic vision, he has a proven track record in driving business growth, expanding market reach, and closing high-profile deals. His expertise includes strategic planning, brand development, and forging meaningful partnerships, enabling him to launch impactful initiatives that resonate on an international scale.
Leo Brommet
Clinical Research Professional (Registered General Nurse) with over 25 years of international hands-on experience in start-up, maintenance and close-out of clinical trials for most therapeutic areas in medical device, diagnostic, biotech, and pharma in early and late phase/ post marketing follow-up/ prospective and retrospective observational registries, directly with Sponsors (startups and global companies), small/ large CRO’s and Imaging Corelabs.
Cecil Wood
Business Development (BD) expert with 20+ years working with biotech, pharma, and healthtech worldwide. Strong scientific foundation in pharmacology. Proven track record (10 years+) across pre-clinical to clinical operations. BD expertise for CROs, core and central labs, data technologies, healthtech and medical devices. Experienced in early- and late-phase clinical trials and go-to-market strategies. BD Consultant for global network spanning biotech, pharma, start-ups, mid-size, and large companies.
Douglas K. Gordon
An accomplished business leader with over 15 years of experience across wellness, cannabis, and psychedelics industries. Founder of the Natural Mystic Center for Wellness in Jamaica, Douglas has built a reputation as a results-driven executive. Known for his strategic vision, he has a proven track record in driving business growth, expanding market reach, and closing high-profile deals. His expertise includes strategic planning, brand development, and forging meaningful partnerships, enabling him to launch impactful initiatives that resonate on an international scale.
Leo Brommet
Clinical Research Professional (Registered General Nurse) with over 25 years of international hands-on experience in start-up, maintenance and close-out of clinical trials for most therapeutic areas in medical device, diagnostic, biotech, and pharma in early and late phase/ post marketing follow-up/ prospective and retrospective observational registries, directly with Sponsors (startups and global companies), small/ large CRO’s and Imaging Corelabs.
Let's Connect
Connect today for expert regulatory and clinical support tailored to you.